Steven Zanganeh, PhD
Assistant Professor
Bioengineering
Contact
508-999-8448
oparaj*v]jc]jad<qi]oo`*a`q
Textiles 228
Education
| 2017 | Stanford University, Stanford, CA | Postdoctoral Scholar |
| 2014 | University of Connecticut, Storrs, CT | PhD in Biomedical Engineering |
| 2009 | K.N.Toosi University of Technology, Tehran, Iran | MS in Materials Science and Engineering |
| 2005 | Azad University, Tehran, Iran | BS in Materials Science and Engineering |
Teaching
- Intro. to Bioengineering
- Bioengineering Lab
Teaching
Programs
Programs
Teaching
Courses
An introduction to laboratory methods in biotechnology and to the biotechnology industry. The course includes genetic engineering, protein manufacture, purification and analysis. The laboratory component includes bioengineering techniques, biosafety, data acquisition and analysis. There is also an introduction to software for engineering analysis and modeling.
An introduction to laboratory methods in biotechnology and to the biotechnology industry. The course includes genetic engineering, protein manufacture, purification and analysis. The laboratory component includes bioengineering techniques, biosafety, data acquisition and analysis. There is also an introduction to software for engineering analysis and modeling.
An introduction to laboratory methods in biotechnology and to the biotechnology industry. The course includes genetic engineering, protein manufacture, purification and analysis. The laboratory component includes bioengineering techniques, biosafety, data acquisition and analysis. There is also an introduction to software for engineering analysis and modeling.
Research
Research Interests
- Value of Nanomaterials for Cancer Immunotherapy
- Sex variation in immunoengineering
Select publications
- S. Zanganeh, et al (2016).
Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues
Nature nanotechnology, 11, 986-994.
Dr. Steven Zanganeh's research goals are directed toward developing immunoengineering systems for high-dimensional analysis of tumor microenvironment, immuno-imaging, and uncovering the overlooked factors in sex-specific variations in nano-immunotherapy. Dr. Zanganeh is planning to link the fields of nanomedicine, immunotherapy, and molecular imaging towards more efficient and accurate diagnosis, personalized therapies and ultimately improving treatment outcomes and patient quality of life. Two major questions in Zangeneh's research are, “What role do nanoparticles play in the tumor microenvironment (TME) to regulate innate and adaptive immune systems?” And, “How and to what extent could cell sex alter the regulation of innate and adaptive immune systems in TME upon treatment with NPs?”